Early-onset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Annals of Hematology

Volumn 74, Issue 2, 1997, Pages 73-77

  Fetscher, S ^a   Finke, J ^a   Engelhardt, R ^a   Mertelsmann, R ^a   Lange, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Autologous bone marrow transplantation; Autologous peripheral blood stem cell transplantation; High dose chemotherapy; Second and secondary primary neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GERM CELL TUMOR; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL TRANSPLANTATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BUSULFAN; CYCLOPHOSPHAMIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY;

EID: 0031058087     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050260     Document Type: Article

References (24)

1. Bhatia S, Ramsay NKC, Steinbuch M, Dusenberry KE, Shapiro RS, Weisdorf DJ, Robison LL, Miller JS, Neglia JP (1996). Malignant neoplasms following bone marrow transplantation. Blood 87:3633-3639
2. Breda M (1995) Is there a need to follow-up cancer patients? Eur J Cancer 31A:655-657
3. Doria R, Holford T, Farber L, Prosnitz LR, Cooper DL (1995) Second solid malignancies after combined modality treatment for Hodgkin's disease. J Clin Oncol 13:2016-2022
4. Fetscher S, Lange W, Finke J, Bertz H, Mertelsmann R (1995) Secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Blood 85 [Suppl 1] abstract 3768
5. Hawkins MM, Wilson LMK, Burton HS, Potok MHN, Winter DI, Marsden HB, Stovall MA (1996) Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88:270-277
6. Johnson BE (1995) Second cancers after successful treatment of small cell lung cancer. Proc Am Soc Clin Oncol 1995 educational book:16-19
7. Johnson BE, Inde DE, Matthews MJ, et al (1986) Non-small cell lung cancer, major cause of late mortality in patients with small cell lung cancer. Am J Med 80:1103-1110
8. Kolb HJJ, Guenther W, Duell T, Socié G, Schaeffer E, Holler E, Schumm M, Horowitz MM, Gale RP, Fliedner TM (1992) Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP study group on late effects. Bone Marrow Transplant 10 [Suppl 1]:135-138
9. Kumar L (1995) Sencondary leukemias after autologous bone marrow transplantation. Lancet 345:810
10. Lassen U, Osterlind Kell, Hansen M, et al (1995) Long-term survival in small-cell lung cancer: post-treatment characteristics in patients surviving 5 to 18+ years - an analysis of 1714 consecutive patients. J Clin Oncol 13:1215-1220
11. Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H (1994) Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 12:2187-2192
12. Mauch PM, Kalish LA, Marcus KC, et al (1991) Secondary malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk-factors and outcome. Blood 78:277-279
13. O'Reilly E, Crown J (1996) Second cancers complicating Hodgkin's disease. Ann Oncol 7:405-408
14. Pedersen-Bjergaard J (1995) Long-term complications of cancer chemotherapy. J Clin Oncol 13:1534-1536
15. Roman-Unfer S, Bilran JD, Hanauer S, Johnson L, Rita D, Booth C, Chen K (1995) Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. Bone Marrow Transplant 16:163-168
16. Sankila R, Garwicz S, Olsen JH, Döllner H, Hertz H, Kreuger A, Langmark F, Larining M. Möller T, Tulinius T (1996) Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446
17. Socié H, Kolb HJ (1995) Malignant diseases after bone marrow transplantation: the case for tumor banking and continued reporting to registries. Bone Marrow Transplant 16:493-495
18. Socié H, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckmann E (1991). Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 78(2):277-279
19. Socié H, Henry-Amar M, Devergie A, Esperou-Bourdeau H, Ribaud O, Traineau R, Gluckmann E (1994) Malignant diseases after allogeneic bone marrow transplantation: an updated overview. Nouv Rev Fr Hematol 36 [Suppl 1]:75-77
20. Tallmann MS, Gray R, Bennett JM, Varaikojis D, Robert N, Wood WC, Rowe JM, Wiernik PH (1995) Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol 13:1557-1563
21. Taylor P, Jackson GH, Lennard A, Hamilton PJ, Proctor SJ (1995) Low frequency of myelodysplasia after autologous bone marrow transplantation. Lancet 345:1248-1249
22. Travis LB, Weeks J, Curlis RE, Chaffey JT, Stovall M, Banks PM, Boice JD (1996) Leukemia following low-dose total body irradiation for non-Hodgkin's lymphoma. J Clin Oncol 14:565-571
23. Vivancos P, Sarrá J, Palou J, García J, Granena A (1996) Kaposi's sarcoma after autologous bone marrow transplantation for multiple myeloma. Bone Marrow Transplant 17:669-671
24. Witherspoon RP, Deeg HJ, Storb R (1994) Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. Transplant Sci 4:33-41